Vockley J, Sondheimer N, Puurunen M, Diaz GA, Ginevic I, Grange DK, Harding C, Northrup H, Phillips JA 3rd, Searle S, Thomas JA, Zori R, Denney WS, Ernst SL, Humphreys K, McWhorter N, Kurtz C, Brennan AM. Efficacy and safety of a synthetic biotic for treatment of phenylketonuria: a phase 2 clinical trial. Nat Metab. 2023 Oct;5(10):1685-1690. PubMed PMID: 37770764
van Vliet K, Dijkstra AM, Bouva MJ, van der Krogt J, Bijsterveld K, van der Sluijs F, de Sain-van der Velden MG, Koop K, Rossi A, Thomas JA, Patera CA, Kiewiet MBG, Waters PJ, Cyr D, Boelen A, van Spronsen FJ, Heiner-Fokkema MR. Maleic acid is a biomarker for maleylacetoacetate isomerase deficiency; implications for newborn screening of tyrosinemia type 1. J Inherit Metab Dis. 2023 Nov;46(6):1104-1113. PubMed PMID: 37545091
Lam C and Thomas JA. Peroxisomal Disorders, Glycosylation Disorders and Smith-Lemli-Opitz Syndrome Presenting in the Newborn. In Avery’s Diseases of the Newborn, 11th edition, Gleason, CA and Sawyer, T editors. Elsevier, 2023.
Lam C and Thomas JA. Peroxisomal Disorders, Glycosylation Disorders and Smith-Lemli-Opitz Syndrome Presenting in the Newborn. In Avery’s Diseases of the Newborn, 11th edition, Taeusch, HW & Ballard, RA editors. W.B. Saunders Co, 2022.
Thomas, JA. Organic Acidemias. In: Nutrition Management of Inherited Metabolic Diseases: Lessons from Metabolic University, 2nd edition. Bernstein LE, Rohr F, van Calcar S editors. Springer Publishing, 2022.
Thomas, JA. Homocystinuria and Cobalamin Disorders. In Nutrition Management of Inherited Metabolic Diseases: Lessons from Metabolic University, 2nd edition. Bernstein LE, Rohr F, van Calcar S editors. Springer Publishing, 2022
Thomas JA, VanHove JLK, Larson A, Baker P. Inborn Errors of Metabolism. In Current Diagnosis and Treatment: Pediatrics, 26th edition, Bunik M, Hay W, Levin M, and Abzug M editors. McGraw-Hill Companies, Inc., 2022
Burton BK, Skalicky A, Baerwald C, Bilder DA, Harding CO, Ilan AB, Jurecki E, Longo N, Madden DT, Sivri HS, Wilcox G, Thomas J, Delaney K. A non-interventional observational study to identify and validate clinical outcome assessments for adults with phenylketonuria for use in clinical trials. Mol Genet Metab Rep. 2021 Dec;29:100810. PubMed PMID: 34815941
Adams D, Andersson HC, Bausell H, Crivelly K, Eggerding C, Lah M, Lilienstein J, Lindstrom K, McNutt M, Ray JW, Saavedra H, Sacharow S, Starin D, Tiffany-Amaro J, Thomas J, Vucko E, Wessenberg LB, Whitehall K. Use of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics. Mol Genet Metab Rep. 2021 Sep;28:100790. PubMed PMID: 34430209
Kripps KA, Baker PR 2nd, Thomas JA, Skillman HE, Bernstein L, Gaughan S, Burns C, Coughlin CR 2nd, McCandless SE, Larson AA, Kochar A, Stillman CF, Wymore EM, Hendricks EG, Woontner M, Van Hove JLK. REVIEW: Practical strategies to maintain anabolism by intravenous nutritional management in children with inborn metabolic diseases. Mol Genet Metab. 2021 Jul;133(3):231-241. PubMed PMID: 33985889
Van Hove JLK, Thomas JA, McCandless SE, Woontner M, Coughlin C. In Memoriam. J Inherit Metab Dis. 2020 Dec 22. [Epub ahead of print] PubMed PMID: 33354834
Burton BK, Longo N, Vockley J, Grange DK, Harding CO, Decker C, Li M, Lau K, Rosen O, Larimore K, Thomas J. Pegvaliase for the treatment of phenylketonuria: Results of the phase 2 dose-finding studies with long-term follow-up. Mol Genet Metab. 2020 Aug;130(4):239-246. PubMed PMID: 32593547
SriBhashyam S, Marsh K, Quartel A, Weng HH, Gershman A, Longo N, Thomas J, Zori R. A benefit-risk analysis of pegvaliase for the treatment of phenylketonuria: A study of patients' preferences. Mol Genet Metab Rep. 2019 Dec;21:100507. PubMed PMID: 31497506
Van Hove JLK, Freehauf CL, Ficicioglu C, Pena LDM, Moreau KL, Henthorn TK, Christians U, Jiang H, Cowan TM, Young SP, Hite M, Friederich MW, Stabler SP, Spector EB, Kronquist KE, Thomas JA, Emmett P, Harrington MJ, Pyle L, Creadon-Swindell G, Wempe MF, MacLean KN. Biomarkers of oxidative stress, inflammation, and vascular dysfunction in inherited cystathionine ß-synthase deficient homocystinuria and the impact of taurine treatment in a phase 1/2 human clinical trial. J Inherit Metab Dis. 2019 May;42(3):424-437. PubMed PMID: 30873612
Longo N, Dimmock D, Levy H, Viau K, Bausell H, Bilder DA, Burton B, Gross C, Northrup H, Rohr F, Sacharow S, Sanchez-Valle A, Stuy M, Thomas J, Vockley J, Zori R, Harding CO. Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria. Genet Med. 2019 Aug;21(8):1851-1867. PubMed PMID: 30546086
Longo N, Dimmock D, Levy H, Viau K, Bausell H, Bilder DA, Burton B, Gross C, Northrup H, Rohr F, Sacharow S, Sanchez-Valle A, Stuy M, Thomas J, Vockley J, Zori R, Harding CO. Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria. Genet Med. 2018 Dec 14. [Epub ahead of print] PubMed PMID: 30546086
Zori R, Thomas JA, Shur N, Rizzo WB, Decker C, Rosen O, Li M, Schweighardt B, Larimore K, Longo N. Induction, titration, and maintenance dosing regimen in a phase 2 study of pegvaliase for control of blood phenylalanine in adults with phenylketonuria. Mol Genet Metab. 2018 Nov;125(3):217-227. PubMed PMID: 30146451
Van Hove JLK, Thomas JA, Baker PR 2nd, Larson AA. In memoriam. J Inherit Metab Dis. 2018 May 7. [Epub ahead of print] PubMed PMID: 29736632
Clarke LA, Atherton AM, Burton BK, Day-Salvatore DL, Kaplan P, Leslie ND, Scott CR, Stockton DW, Thomas JA, Muenzer J. Mucopolysaccharidosis Type I Newborn Screening: Best Practices for Diagnosis and Management. J Pediatr. 2017 Mar;182:363-370. PubMed PMID: 27939258
Clarke LA, Atherton AM, Burton BK, Day-Salvatore DL, Kaplan P, Leslie ND, Scott CR, Stockton DW, Thomas JA, Muenzer J. Mucopolysaccharidosis Type I Newborn Screening: Best Practices for Diagnosis and Management. J Pediatr. 2016 Dec 7. [Epub ahead of print] PubMed PMID: 27939258
Chatfield KC, Coughlin CR 2nd, Friederich MW, Gallagher RC, Hesselberth JR, Lovell MA, Ofman R, Swanson MA, Thomas JA, Wanders RJ, Wartchow EP, Van Hove JL. Mitochondrial energy failure in HSD10 disease is due to defective mtDNA transcript processing. Mitochondrion. 2015 Jan 6;21C:1-10. [Epub ahead of print] PubMed PMID: 25575635
Chien YH, Abdenur JE, Baronio F, Bannick AA, Corrales F, Couce M, Donner MG, Ficicioglu C, Freehauf C, Frithiof D, Gotway G, Hirabayashi K, Hofstede F, Hoganson G, Hwu WL, James P, Kim S, Korman SH, Lachmann R, Levy H, Lindner M, Lykopoulou L, Mayatepek E, Muntau A, Okano Y, Raymond K, Rubio-Gozalbo E, Scholl-Bürgi S, Schulze A, Singh R, Stabler S, Stuy M, Thomas J, Wagner C, Wilson WG, Wortmann S, Yamamoto S, Pao M, Blom HJ. Mudd's disease (MAT I/III deficiency): a survey of data for MAT1A homozygotes and compound heterozygotes. Orphanet J Rare Dis. 2015 Aug 20;10:99. PubMed PMID: 26289392
Chatfield KC, Coughlin CR 2nd, Friederich MW, Gallagher RC, Hesselberth JR, Lovell MA, Ofman R, Swanson MA, Thomas JA, Wanders RJ, Wartchow EP, Van Hove JL. Mitochondrial energy failure in HSD10 disease is due to defective mtDNA transcript processing. Mitochondrion. 2015 Mar;21:1-10. PubMed PMID: 25575635
Stence NV, Coughlin CR 2nd, Fenton LZ, Thomas JA. Distinctive pattern of restricted diffusion in a neonate with molybdenum cofactor deficiency. Pediatr Radiol. 2012 Dec 19. [Epub ahead of print] PubMed PMID: 23250031
Kripps KA, Baker PR, Thomas JA, Skillman HE, Bernstein LE, Gaughan S, Burns C, Coughlin CR, McCandless SE, Larson AA, Kochhar A, Stillman C, Wymore E, Hendricks E, Woontner M. Practical strategies to maintain anabolism by intravenous nutritional management in children with inborn metabolic diseases. Molecular Genetics and Metabolism. Submitted.
Thomas, JA. Homocystinuria and Cobalamin Disorders. In Nutrition Management of Inherited Metabolic Diseases: Lessons from Metabolic University, 2nd edition. Bernstein LE, Rohr F, Helm J editors. Springer Publishing, Submitted.
Thomas, JA. Organic Acidemias. In: Nutrition Management of Inherited Metabolic Diseases: Lessons from Metabolic University, 2nd edition. Bernstein LE, Rohr F, Helm J editors. Springer Publishing, Submitted.
Thomas JA, VanHove JLK, Baker P. Inborn Errors of Metabolism. In Current Diagnosis and Treatment: Pediatrics, 25th edition, Hay W, Levin M, Sondheimer J, and Deterding R editors. McGraw-Hill Companies, Inc., Submitted.
Harding CO, Longo N, Northrup H, Sacharow S, Singh R, Thomas J, Vockley J, Zori RT, Bulloch Whitehall K, Lilienstein J, Lindstrom K, Levy DG, Jones S, Burton BK (2023). Pegvaliase for the treatment of phenylketonuria: Final results of a long-term Phase 3 clinical trial program. Molecular Genetics and Metabolism. Submitted